Dova Pharmaceuticals Inc. plans to sell 2.5 million of its common shares in an underwritten public offering.
The company also plans grant the underwriters an option to buy up to an additional 375,000 common shares.
J.P. Morgan Securities LLC, Jefferies LLC and Evercore Group LLC are serving as joint book-running managers for the offering.
